242 related articles for article (PubMed ID: 17219733)
1. Novel drug resistance mutations in HIV: recognition and clinical relevance.
Perno CF; Svicher V; Ceccherini-Silberstein F
AIDS Rev; 2006; 8(4):179-90. PubMed ID: 17219733
[TBL] [Abstract][Full Text] [Related]
2. Interactive selective pressures of HLA-restricted immune responses and antiretroviral drugs on HIV-1.
John M; Moore CB; James IR; Mallal SA
Antivir Ther; 2005; 10(4):551-5. PubMed ID: 16038481
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China.
Liu J; Yue J; Wu S; Yan Y
Arch Virol; 2007; 152(10):1799-805. PubMed ID: 17619115
[TBL] [Abstract][Full Text] [Related]
4. Characterization of drug-resistance mutations in HIV-1 isolates from non-HAART and HAART treated patients in Burkina Faso.
Nadembega WM; Giannella S; Simpore J; Ceccherini-Silberstein F; Pietra V; Bertoli A; Pignatelli S; Bellocchi MC; Nikiema JB; Cappelli G; Bere A; Colizzi V; Perno CP; Musumeci S
J Med Virol; 2006 Nov; 78(11):1385-91. PubMed ID: 16998878
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 drug resistance mutations in children who failed non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.
Sungkanuparph S; Apiwattanakul N; Thitithanyanont A; Chantratita W; Sirinavin S
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):83-8. PubMed ID: 19323038
[TBL] [Abstract][Full Text] [Related]
6. 2004: which HIV-1 drug resistance mutations are common in clinical practice?
Cheung PK; Wynhoven B; Harrigan PR
AIDS Rev; 2004; 6(2):107-16. PubMed ID: 15332433
[TBL] [Abstract][Full Text] [Related]
7. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.
Yaotsè DA; Nicole V; Roch NF; Mireille PD; Eric D; Martine P
Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus type 1 protease and reverse transcriptase mutation patterns among treatment-naive patients in different stages of infection in Rio de Janeiro, Brazil.
Varella RB; Ferreira SB; de Castro MB; Zalis MG; Tavares MD
J Med Virol; 2007 Aug; 79(8):1033-9. PubMed ID: 17596836
[TBL] [Abstract][Full Text] [Related]
9. Compensatory mutations at the HIV cleavage sites p7/p1 and p1/p6-gag in therapy-naive and therapy-experienced patients.
Verheyen J; Litau E; Sing T; Däumer M; Balduin M; Oette M; Fätkenheuer G; Rockstroh JK; Schuldenzucker U; Hoffmann D; Pfister H; Kaiser R
Antivir Ther; 2006; 11(7):879-87. PubMed ID: 17302250
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo.
Martinez-Picado J; Martínez MA
Virus Res; 2008 Jun; 134(1-2):104-23. PubMed ID: 18289713
[TBL] [Abstract][Full Text] [Related]
11. HIV-1-resistant strains during 8-week on 8-week off intermittent therapy and their effect on CD4+ T-cell counts and antiviral response.
Izopet J; Marchou B; Charreau I; Sauné K; Tangre P; Molina JM; Aboulker JP;
Antivir Ther; 2008; 13(4):537-45. PubMed ID: 18672532
[TBL] [Abstract][Full Text] [Related]
12. Characterization and structural analysis of HIV-1 integrase conservation.
Ceccherini-Silberstein F; Malet I; D'Arrigo R; Antinori A; Marcelin AG; Perno CF
AIDS Rev; 2009; 11(1):17-29. PubMed ID: 19290031
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of HIV drug resistance to nucleoside and nucleotide reverse transcriptase inhibitors.
Geretti AM
AIDS Rev; 2006; 8(4):210-20. PubMed ID: 17219736
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
Cardoso LP; Queiroz BB; Stefani MM
J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948
[TBL] [Abstract][Full Text] [Related]
15. Update of the drug resistance mutations in HIV-1: Fall 2006.
Johnson VA; Brun-Vezinet F; Clotet B; Kuritzkes DR; Pillay D; Schapiro JM; Richman DD
Top HIV Med; 2006; 14(3):125-30. PubMed ID: 16946457
[TBL] [Abstract][Full Text] [Related]
16. Progressive reversion of human immunodeficiency virus type 1 resistance mutations in vivo after transmission of a multiply drug-resistant virus.
Gandhi RT; Wurcel A; Rosenberg ES; Johnston MN; Hellmann N; Bates M; Hirsch MS; Walker BD
Clin Infect Dis; 2003 Dec; 37(12):1693-8. PubMed ID: 14689353
[TBL] [Abstract][Full Text] [Related]
17. Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy.
Di Giambenedetto S; Zazzi M; Corsi P; Gonnelli A; Di Pietro M; Giacometti A; Almi P; Trezzi M; Boeri E; Gianotti N; Menzo S; Del Gobbo R; Francisci D; Nerli A; Galli L; De Luca A;
Antivir Ther; 2009; 14(3):359-69. PubMed ID: 19474470
[TBL] [Abstract][Full Text] [Related]
18. Update of the drug resistance mutations in HIV-1: Fall 2005.
Johnson VA; Brun-Vezinet F; Clotet B; Conway B; Kuritzkes DR; Pillay D; Schapiro JM; Telenti A; Richman DD
Top HIV Med; 2005; 13(4):125-31. PubMed ID: 16304457
[TBL] [Abstract][Full Text] [Related]
19. Genotypic resistance mutations in treatment-naïve and treatment-experienced patients under widespread use of antiretroviral drugs in Thailand: implications for further epidemiologic surveillance.
Sukasem C; Churdboonchart V; Sirisidthi K; Riengrojpitak S; Chasombat S; Watitpun C; Piroj W; Tiensuwan M; Chantratita W
Jpn J Infect Dis; 2007 Sep; 60(5):284-9. PubMed ID: 17881868
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART.
Saracino A; Gianotti N; Marangi M; Cibelli DC; Galli A; Punzi G; Monno L; Lazzarin A; Angarano G;
J Med Virol; 2008 Oct; 80(10):1695-706. PubMed ID: 18712823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]